Table 2.
Reagents proposed to act via VDAC (for details, see VDAC as a Pharmacological Target for Compounds Affecting Cell Proliferation or Apoptosis).
Agents | VDAC-mediated cytotoxic | Reference |
---|---|---|
Avicins | Pro-apoptotic plant stress metabolites, target and close VDAC | Haridas et al. (2007) |
Fluoxetine (Prozac) | Anti-depressant induces cell proliferation and cell-line dependent apoptotic modulator. Interacts directly with VDAC, inhibits PTP opening and apoptosis |
Nahon et al. (2005) |
Cisplatin | Interacts directly with VDAC1 and inhibits PTP opening | Castagna et al. (2004), Yang et al. (2006) |
Acrolein | α,β-Unsaturated aldehydes, carbonylates VDAC in Alzheimer’s disease | Mello et al. (2007) |
Erastin | Anti-cancer agent that binds directly to VDAC2 to induce cell death | Yagoda et al. (2007) |
Endostatin | Small collagen type XVIII fragment, angiogenesis inhibitor. Interacts with VDAC1, inducing PTP opening | Yuan et al. (2008) |
Oblimersen | 18-mer phosphorothioate anti-sense oligonucleotide. Binds directly to VDAC, blocks channel activity, pro-apoptotic | Tan et al. (2007) |
Furanonaphthoquinones | Induce caspase-dependent apoptosis. FNQ-mediated apoptosis is VDAC-dependent | Simamura et al. (2008) |
Geldanamycin 17AAG | Binds to VDAC and inhibits cell invasion | Xie et al. (2011) |